Clinical Trial Update: Therapeutic Effect of Dapagliflozin Combined With CSII on Newly Diagnosed Type 2 Diabetes Mellitus [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial updating on the therapeutic effect of dapagliflozin combined with CSII in newly diagnosed type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Dapagliflozin (dapagliflozin)

Snippet

Sponsor: Nanjing First Hospital, Nanjing Medical University | Conditions: Type 2 Diabetes Mellitus | Phase 4 | Status: UNKNOWN